IL162154A0 - Prostagandin composition for the treatment of erectile dysfunction - Google Patents

Prostagandin composition for the treatment of erectile dysfunction

Info

Publication number
IL162154A0
IL162154A0 IL16215403A IL16215403A IL162154A0 IL 162154 A0 IL162154 A0 IL 162154A0 IL 16215403 A IL16215403 A IL 16215403A IL 16215403 A IL16215403 A IL 16215403A IL 162154 A0 IL162154 A0 IL 162154A0
Authority
IL
Israel
Prior art keywords
prostagandin
treatment
composition
erectile dysfunction
erectile
Prior art date
Application number
IL16215403A
Other languages
English (en)
Original Assignee
Nexmed Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexmed Holdings Inc filed Critical Nexmed Holdings Inc
Publication of IL162154A0 publication Critical patent/IL162154A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16215403A 2002-02-15 2003-02-14 Prostagandin composition for the treatment of erectile dysfunction IL162154A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35728202P 2002-02-15 2002-02-15
PCT/US2003/004560 WO2003070281A1 (en) 2002-02-15 2003-02-14 Prostaglandin composition for the treatment of erectile dysfunction

Publications (1)

Publication Number Publication Date
IL162154A0 true IL162154A0 (en) 2005-11-20

Family

ID=27757591

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16215403A IL162154A0 (en) 2002-02-15 2003-02-14 Prostagandin composition for the treatment of erectile dysfunction

Country Status (13)

Country Link
US (1) US20030220292A1 (xx)
EP (1) EP1482980A1 (xx)
JP (1) JP2005517725A (xx)
KR (1) KR20040082431A (xx)
CN (1) CN1610559A (xx)
AU (1) AU2003211077A1 (xx)
BR (1) BR0307345A (xx)
CA (1) CA2468631A1 (xx)
HU (1) HUP0402673A2 (xx)
IL (1) IL162154A0 (xx)
MX (1) MXPA04007828A (xx)
WO (1) WO2003070281A1 (xx)
ZA (1) ZA200404105B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105571B2 (en) 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
KR20050057245A (ko) * 2002-09-06 2005-06-16 넥스메드 홀딩스 인코포레이티드 남성 발기 부전을 치료하는 방법
US20040241243A1 (en) * 2003-03-21 2004-12-02 Nexmed (Holdings) Inc. Angiogenesis promotion by prostaglandin compositions and methods
CN1761461B (zh) * 2003-03-21 2010-05-05 奈克斯麦德控股有限公司 前列腺素组合物在制备治疗早泄的药物中的应用
US8068910B2 (en) 2005-04-28 2011-11-29 Medtronic, Inc. Flexible tube sensor for sensing urinary sphincter pressure
US7610093B2 (en) * 2005-04-28 2009-10-27 Medtronic, Inc. Implantable optical pressure sensor for sensing urinary sphincter pressure
US7623923B2 (en) * 2005-04-28 2009-11-24 Medtronic, Inc. Tube sensor for penile tumescence
US7328070B2 (en) 2005-04-28 2008-02-05 Medtronic, Inc. Multi-tube sensor for sensing urinary sphincter and urethral pressure
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
WO2010070617A1 (en) * 2008-12-19 2010-06-24 Shimoda Biotech (Pty) Ltd Inclusion complexes of alpha-cyclodextrin and sildenafil salt
CN109999359B (zh) * 2019-01-24 2021-08-13 西安蓝极医疗电子科技有限公司 基于多波长激光治疗男性勃起功能障碍的装置
CN114324674A (zh) * 2022-01-21 2022-04-12 苏州南医大创新中心 一种精液中与无精子症有关的分子标志物及其检测方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595975A (en) * 1969-07-29 1971-07-27 Holliston Lab Inc Disinfecting compositions
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US6121276A (en) * 1994-04-22 2000-09-19 Pentech Pharmaceuticals, Inc. Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
NZ331549A (en) * 1996-01-29 2000-09-29 Univ California Compounds useful in treating sexual dysfunction
US6037346A (en) * 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US5919474A (en) * 1997-10-28 1999-07-06 Vivus, Inc. Transurethral administration of vasoactive agents to treat peripheral vascular disease, related vascular diseases, and vascular impotence associated therewith
US6414028B1 (en) * 1997-11-05 2002-07-02 Nexmed Holdings, Inc. Topical compositions containing prostaglandin E1
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
US6486207B2 (en) * 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6323241B1 (en) * 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction

Also Published As

Publication number Publication date
AU2003211077A1 (en) 2003-09-09
CA2468631A1 (en) 2003-08-28
US20030220292A1 (en) 2003-11-27
WO2003070281A1 (en) 2003-08-28
EP1482980A1 (en) 2004-12-08
ZA200404105B (en) 2005-08-26
CN1610559A (zh) 2005-04-27
MXPA04007828A (es) 2004-10-15
BR0307345A (pt) 2004-12-14
JP2005517725A (ja) 2005-06-16
HUP0402673A2 (hu) 2005-04-28
KR20040082431A (ko) 2004-09-24

Similar Documents

Publication Publication Date Title
PL377729A1 (pl) Sposób leczenia dysfunkcji seksualnej
IL157320A0 (en) Rapid-onset medicament for the treatment of sexual dysfunction
AU2003248888A8 (en) Peptide composition for treatment of sexual dysfunction
HUS2200036I1 (hu) Dihidroimidazolonok alkalmazása kutyák kezelésére
AU2003274342A8 (en) Compositions for the treatment of autoimmune disorders
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
AU2001250821A1 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
IL162154A0 (en) Prostagandin composition for the treatment of erectile dysfunction
AU2003219981A1 (en) Benzimidazole-derivatives for the treatment of sexual dysfunction
EP1677754A4 (en) METHOD AND COMPOSITIONS FOR TREATING THE EFFECTIVE DYSFUNCTION
EP1648430A4 (en) TREATMENT FOR EJACULATIO PRAECOX
IL162455A0 (en) Compounds for the treatment of sexual dysfunction
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
AU2003270683A8 (en) Compounds for the treatment of premature ejaculation
AU2002246924A8 (en) Treatment of erectile dysfunction with rho-kinase inhibitors
IL166273A0 (en) Methods of treatment of male erectile dysfunction
AU2003270202A8 (en) Pharmaceutical compositions useful for the treatment of cancers
AU8906201A (en) Methods and compositions for the treatment and prevention of sexual dysfunction
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
GB0313630D0 (en) Compositions for the enhanced treatment of depression
EP1648469A4 (en) ANTIGLUCOCORTICOIDES FOR THE TREATMENT OF CATATONIA
GB0221712D0 (en) Methods of treatment
GB0323846D0 (en) Treatment of erectile dysfunction
HK1073109A1 (en) Pharmaceutical composition for treatment of male sexual dysfunction